Prevalence of Advanced Fibrosis in Patients Living With HIV (FLASH)
Cross-sectional Study on the Prevalence of Fatty Liver and Metabolic Risk Factors in an HIV-infected Population
Sponsor: Johannes Gutenberg University Mainz
This observational or N/A phase trial investigates Fatty Liver Disease and is currently ongoing. Johannes Gutenberg University Mainz leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Enrolling By Invitation
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation
-
Jan 2024 — Jul 2024 [monthly]
Enrolling By Invitation
-
Jan 2022 — Jan 2024 [monthly]
Enrolling By Invitation
Status: Unknown Status → Enrolling By Invitation
-
Nov 2021 — Jan 2022 [monthly]
Unknown Status
Status: Enrolling By Invitation → Unknown Status
▶ Show 2 earlier versions
-
Jan 2021 — Nov 2021 [monthly]
Enrolling By Invitation
-
Sep 2019 — Jan 2021 [monthly]
Enrolling By Invitation
First recorded
Oct 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Johannes Gutenberg University Mainz
For direct contact, visit the study record on ClinicalTrials.gov .